scorecardresearch
Add as a preferred source on Google
Saturday, October 4, 2025
TopicSun Pharmaceutical

Topic: Sun Pharmaceutical

Govt panel rejects Sun Pharma plea seeking emergency use nod for dengue drug to treat Covid

Sun Pharmaceutical had sought grant of 'emergency authorisation status' to its plant-based drug, ACQH, which is being developed as a potential treatment for dengue.

Sun Pharma gets approval to test plant-based dengue drug for Covid treatment

Sun Pharma said human safety study of AQCH already completed, clinical trials will be conducted across 12 centres on 210 patients. The treatment duration will be 10 days.

Sun Pharma’s plant-based under trial dengue drug could be tested for Covid treatment

The Mumbai-based drug-maker has submitted a proposal to the govt to conduct Phase II clinical trials of the drug to see if it can treat patients suffering from Covid-19.

Sun Pharmaceuticals undergoes SEBI-ordered forensic audit

The latest probe points to challenges for India’s biggest drugmaker after whistle-blower complaints on corporate governance lapses triggered a stock slide last year.

Dilip Shanghvi of Sun Pharmaceutical’s to keep stake in Suzlon Energy despite falling value

In 2015, billionaire Dilip Shanghvi bought 23% stake for Rs 18 billion, but Suzlon still hasn’t exited India’s debt-restructuring program, missing deadlines since 2017.

On Camera

6 reasons Trump’s Gaza plan won’t work—even if Hamas accepts it

On paper, the 21-point plan looks balanced—Palestinian governance, international oversight, reconstruction pledges. But in reality, it is a non-negotiable diktat.

Nodal officers to fast-tracking NOCs, Kerala govt’s heeding investor concerns, and it means business

As many as 21 policy reforms are under implementation following Invest Kerala Global Summit, as LDF govt works to change perception that the state is not conducive to businesses.

Army chief’s big warning to Pakistan: Stop sponsoring terrorism if you want to exist geographically

Amid continued concerns over cross-border terrorism, General Upendra Dwivedi further warned the neighbour that India will not show restraint if there is an Op Sindoor 2.0.

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.